XML 127 R113.htm IDEA: XBRL DOCUMENT v3.20.4
Earnings Per Common Share - Computation of EPS (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Numerator                      
Income from continuing operations $ (19,204) $ (27,762) $ 60,341 $ 147,132 $ 153,320 $ (24,420) $ 24,052 $ 22,517 $ 160,507 $ 175,469 $ 837,218
Noncontrolling interests' share in continuing operations                 (14,394) (14,558) (12,294)
Income (loss) from continuing operations attributable to Healthpeak Properties, Inc.                 146,113 160,911 824,924
Participating securities' share in earnings                 (2,416) (1,543) (2,669)
Income (loss) from continuing operations applicable to common shares                 143,697 159,368 822,255
Income (loss) from discontinued operations $ 169,449 $ (31,819) $ (5,292) $ 135,408 $ (105,961) $ (17,888) $ (34,032) $ 42,473 267,746 (115,408) 236,256
Noncontrolling interests' share in discontinued operations                 (296) 27 (87)
Net income (loss) applicable to common shares                 411,147 43,987 1,058,424
Add: distributions on dilutive convertible units and other                 0 0 6,919
Dilutive net income (loss) available to common shares                 $ 411,147 $ 43,987 $ 1,065,343
Denominator                      
Basic weighted average shares outstanding (in shares)                 530,555 486,255 470,551
Dilutive potential common shares - equity awards (in shares)                 300 309 168
Weighted-average incremental shares from forward equity sales agreements (in shares)                 201 2,771 0
Dilutive potential common shares - DownREIT conversions (in shares)                 0 0 4,668
Diluted weighted average common shares (in shares)                 531,056 489,335 475,387
Basic earnings (loss) per common share:                      
Continuing operations (in dollars per share) $ (0.04) $ (0.06) $ 0.10 $ 0.28 $ 0.30 $ (0.06) $ 0.04 $ 0.04 $ 0.27 $ 0.33 $ 1.75
Discontinued operations (in dollars per share) 0.31 (0.06) (0.01) 0.27 (0.21) (0.03) (0.07) 0.09 0.50 (0.24) 0.50
Net income (loss) applicable to common shares (in dollars per share)                 0.77 0.09 2.25
Diluted earnings per common share                      
Continuing operations (in dollars per share) (0.04) (0.06) 0.10 0.28 0.30 (0.06) 0.04 0.04 0.27 0.33 1.74
Discontinued operations (in dollars per share) $ 0.31 $ (0.06) $ (0.01) $ 0.26 $ (0.21) $ (0.03) $ (0.07) $ 0.09 0.50 (0.24) 0.50
Net income (loss) applicable to common shares (in dollars per share)                 $ 0.77 $ 0.09 $ 2.24
Outstanding equity awards (in shares)                 1,000    
Forward sales agreements that have been settled (in shares)                 32,000 21,000  
Forward sales agreements that have not been settled (in shares)                   30,000